Therapeutic outcome in neuropathic pain: Relationship to evidence of nervous system lesion

European Journal of Neurology

Volumn 11, Issue 8, 2004, Pages 545-553

  Rasmussen, P V ^a   Sindrup, S H ^b   Jensen, T S ^a   Bach, F W ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Allodynia; Gabapentin; Imipramine; Nervous system lesion; Neuropathic pain; Quantitative sensory test

Indexed keywords

ANALGESIC AGENT; DESIPRAMINE; GABAPENTIN; IMIPRAMINE;

ADULT; AGED; ALLODYNIA; ANALGESIA; ANAMNESIS; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG BLOOD LEVEL; ELECTROPHYSIOLOGY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVOUS SYSTEM INJURY; NEUROIMAGING; NEUROPATHIC PAIN; PRIORITY JOURNAL; SENSORY DYSFUNCTION; SENSORY SYSTEM EXAMINATION; SIDE EFFECT; TEMPERATURE SENSE; TREATMENT FAILURE; TREATMENT OUTCOME;

ACETIC ACIDS; ADULT; AGED; AMINES; CHI-SQUARE DISTRIBUTION; CYCLOHEXANECARBOXYLIC ACIDS; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; IMIPRAMINE; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; SENSATION DISORDERS; TRAUMA, NERVOUS SYSTEM; TREATMENT OUTCOME;

EID: 4043148534     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2004.00843.x     Document Type: Article

References (34)

1. Attal N, Gaude V, Brasseur L et al. (2000). Intravenous lidocaine in central pain: a double-blind, placebo-controlled, psychophysical study. Neurology 54:564-574.
2. Attal N, Guirimand F, Brasseur L, Gaude V, Chauvin M, Bouhassira D (2002). Effects of IV morphine in central pain: a randomized placebo-controlled study. Neurology 58:554-563.
3. Backonja M, Beydoun A, Edwards KR et al. (1998). Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 280:1831-1836.
4. Bech P, Rasmussen N, Olsen LR, Noerholm V, Abildgaard W (2001). The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index of diagnostic validity. J Affect Disord 66:159-164.
5. Cook RJ, Sackett DL (1995). The number needed to treat: a clinically useful measure of treatment effect. BMJ 310:452-454.
6. Drewes AM, Helweg-Larsen S, Petersen P et al. (1993). McGill Pain Questionnaire translated into Danish: experimental and clinical findings. Clin J Pain 9:80-87.
7. Eide PK, Jorum E, Stubhaug A, Bremnes J, Breivik H (1994). Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo. Pain 58:347-354.
8. Farrar JT, Young JPJ, LaMoreaux L, Werth JL, Poole RM (2001). Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94:149-158.
9. Felsby S, Nielsen J, Arendt-Nielsen L, Jensen TS (1996). NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride. Pain 64, 283-291.
10. Fruhstorfer H, Lindblom U, Schmidt WC (1976), Method for quantitative estimation of thermal thresholds in patients. J Neurol Neurosurg Psychiatry 39:1071-1075.
11. Gottrup H, Nielsen J, Arendt-Nielsen L, Jensen TS (1998). The relationship between sensory thresholds and mechanical hyperalgesia in nerve injury. Pain 75:321-329.
12. Hansson P, Lacerenza M, Marchettini P (2001). Aspects of clinical and experimental neuropathic pain: the clinical perspective. In: Hansson PT, Field HL, Hill RG, Marchetttini P, eds. Neuropathic Pain: Pathophysiology and Treatment. IASP Press, Seattle, WA, pp. 1-19.
13. Hilz MJ, Stemper B, Axelrod FB, Kolodny EH, Neundorfer B. (1999). Quantitative thermal perception testing in adults. J Clin Neurophysiol 16:462-471.
14. Jensen TS (2002). Anticonvulsants in neuropathic pain: rationale and clinical evidence. Eur J Pain 6(Suppl. A):61-68.
15. Jensen TS, Bach FW, Kastrup J, Dejgaard A, Brennum J (1991). Vibratory and thermal thresholds in diabetics with and without clinical neuropathy. Acta Neurol Scand 84:326-333.
16. Kalso E, Tasmuth T, Neuvonen PJ (1996). Amitriptyline effectively relieves neuropathic pain following treatment of breast cancer. Pain 64:293-302.
17. Leijon G, Boivie J (1989). Central post-stroke pain - a controlled trial of amitriptyline and carbamazepine. Pain 36:27-36.
18. Max MB, Culnane M, Schafer SC et al. (1987). Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 37:589-596.
19. Max MB, Schafer SC, Culnane M, Smoller B, Dubner R, Gracely RH (1988). Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology 38, 1427-1432.
20. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. (1992). Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 326:1250-1256.
21. Melzack R (1987). The short-form McGill Pain Questionnaire. Pain 30:191-197.
22. Nikolajsen L, Hansen CL, Nielsen J, Keller J, Arendt-Nielsen L, Jensen TS (1996). The effect of ketamine on phantom pain: a central neuropathic disorder maintained by peripheral input. Pain 67:69-77.
23. Olesen OV, Plougmann P, Linnet K. (2000). Determination of nortriptyline in human serum by fully automated solid-phase extraction and on-line high-performance liquid chromatography in the presence of anti psychotic drugs. J Chromatogr B 746:233-239.
24. Rice AS, Maton S (2001). Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain 94:215-224.
25. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L (1998). Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 280:1837-1842.
26. Serpell MG. (2002). Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial. Pain 99:557-566.
27. Sindrup SH, Jensen TS (1999). Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 83:389-400.
28. Sindrup SH, Ejlertsen B, Froland A, Sindrup EH, Brosen K, Gram LF (1989). Imipramine treatment in diabetic neuropathy: relief of subjective symptoms without changes in peripheral and autonomic nerve function. Eur J Clin Pharmacol 37:151-153.
29. Sindrup SH, Gram LF, Skjold T, Froland A, Beck-Nielsen H (1990). Concentration-response relationship in imipramine treatment of diabetic neuropathy symptoms. Clin Pharmacol Ther 47:509-515.
30. Stubhaug A, Breivik H, Eide PK, Kreunen M, Foss A (1997). Mapping of punctuate hyperalgesia around a surgical incision demonstrates that ketamine is a powerful suppressor of central sensitization to pain following surgery. Acta Anaesthesiol Scand 41:1124-1132.
31. Verdugo R, Ochoa JL (1992). Quantitative somatosensory thermotest. A key method for functional evaluation of small calibre afferent channels. Brain 115:893-913.
32. Vestergaard K, Andersen G, Gottrup H, Kristensen BT, Jensen TS (2001). Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology 56:184-190.
33. Woolf CJ, Decosterd I (1999). Implications of recent advances in the understanding of pain pathophysiology for the assessment of pain in patients. Pain Suppl 6:S141-S147.
34. Woolf CJ, Salter MW (2000). Neuronal plasticity: increasing the gain in pain. Science 288:1765-1769.